Frankfurt - Delayed Quote EUR

FibroGen, Inc. (1FG.F)

Compare
0.3715
-0.0008
(-0.21%)
At close: 8:08:28 AM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
180,015
147,752
140,734
235,309
176,319
Cost of Revenue
41,634
18,848
20,280
12,871
8,869
Gross Profit
138,381
128,904
120,454
222,438
167,450
Operating Expense
232,782
398,113
421,479
510,968
359,330
Operating Income
-94,401
-269,209
-301,025
-288,530
-191,880
Net Non Operating Interest Income Expense
-12,254
-5,052
6,156
-2,153
3,151
Other Income Expense
-18,554
-12,606
--
--
-202
Pretax Income
-125,209
-286,867
-294,869
-290,683
-188,729
Tax Provision
-137
3
358
347
360
Earnings from Equity Interest Net of Tax
3,279
2,638
1,573
1,007
-202
Net Income Common Stockholders
-121,793
-284,232
-293,654
-290,023
-189,291
Diluted NI Available to Com Stockholders
-121,793
-284,232
-293,654
-290,023
-189,291
Basic EPS
-1.23
-2.92
-3.14
-3.14
-2.11
Diluted EPS
-1.23
-2.92
-3.14
-3.14
-2.11
Basic Average Shares
99,462.2500
97,303
93,582
92,349
89,854
Diluted Average Shares
99,462.2500
97,303
93,582
92,349
89,854
Total Operating Income as Reported
-112,955
-281,815
-301,025
-288,530
-191,880
Total Expenses
274,416
416,961
441,759
523,839
368,199
Net Income from Continuing & Discontinued Operation
-121,793
-284,232
-293,654
-290,023
-189,291
Normalized Income
-103,259.3012
-274,273.2600
-293,654
-290,023
-189,291
Interest Income
7,588
10,480
7,596
--
5,553
Interest Expense
19,842
15,532
1,440
2,153
2,402
Net Interest Income
-12,254
-5,052
6,156
-2,153
3,151
EBIT
-105,367
-271,335
-293,429
-288,530
-186,327
EBITDA
-101,152
-261,405
-282,825
-273,721
-164,280
Reconciled Cost of Revenue
41,634
18,848
20,280
12,871
8,869
Reconciled Depreciation
4,215
9,930
10,604
14,809
22,047
Net Income from Continuing Operation Net Minority Interest
-121,793
-284,232
-293,654
-290,023
-189,291
Total Unusual Items Excluding Goodwill
-18,554
-12,606
--
--
-202
Total Unusual Items
-18,554
-12,606
--
--
-202
Normalized EBITDA
-82,598
-248,799
-282,825
-273,721
-164,280
Tax Rate for Calcs
0
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-20.3012
-2,647.2600
--
--
--
12/31/2020 - 11/19/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NB11.F Vaxart, Inc.
0.4818
-1.79%
 
MBIO.CN MindBio Therapeutics Corp.
0.0200
+33.33%
 
ARTL Artelo Biosciences, Inc.
1.0000
-6.54%
 
ATXS Astria Therapeutics, Inc.
6.10
-5.28%
 
SCPX Scorpius Holdings, Inc.
0.1621
-5.20%
 
CTMX CytomX Therapeutics, Inc.
0.6503
-3.97%
 
ALLR Allarity Therapeutics, Inc.
0.8801
+10.19%
 
NKTR Nektar Therapeutics
0.8019
-4.54%
 
RENB Renovaro Inc.
0.8937
-9.05%
 
CDT Conduit Pharmaceuticals Inc.
1.1600
-3.33%